(Q35136988)

6 August 2017

title

Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial (English)

1 reference

6 August 2017

0 references

Antonio Uccelli

10

0 references

Alessandra Lugaresi

object named as

Alessandra Lugaresi

7

0 references

Gianluigi Mancardi

object named as

Giovanni Luigi Mancardi

11

0 references

Giancarlo Comi

6

object named as

Giancarlo Comi

1 reference

ORCID Public Data File 2021

6 August 2017

1 reference

Bruno Giometto

1 reference

ORCID Public Data File 2021

author name string

Alice Laroni

1

1 reference

6 August 2017

Davide Brogi

2

1 reference

6 August 2017

Vincenzo Brescia Morra

3

1 reference

6 August 2017

Leonello Guidi

4

1 reference

6 August 2017

Carlo Pozzilli

5

1 reference

6 August 2017

Renato Turrini

8

1 reference

6 August 2017

Debora Raimondi

9

1 reference

6 August 2017

EAP Investigators

12

1 reference

6 August 2017

publication date

1 April 2014

1 reference

6 August 2017

1 reference

6 August 2017

volume

14

1 reference

6 August 2017

page(s)

65

1 reference

A patient with Leiden V mutation, multiple sclerosis, psoriasis, and sicca syndrome: could celecoxib and fingolimod adversely affect the heart?

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005629

Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005629

The changing face of multiple sclerosis clinical trial populations

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005629

Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005629

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005629

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005629

Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005629

Oral fingolimod (FTY720) for relapsing multiple sclerosis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005629

First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4005629

Delayed fingolimod-associated asystole

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24690227

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2377-14-65

1 reference

Dimensions Publication ID

6 August 2017

0 references

1 reference

6 August 2017

1 reference